NCT07103694View on ClinicalTrials.gov

i-NEED: NEw migrainE Drugs Database

RecruitingOBSERVATIONAL
Enrollment

2,641

Participants

Timeline

Start Date

March 24, 2022

Primary Completion Date

December 30, 2025

Study Completion Date

December 31, 2025

Conditions
Episodic MigraineChronic MigraineMedication Overuse Headache
Interventions
DRUG

anti-CGRP monoclonal antibodies

erenumab, fremanezumab, galcanezumab, eptinezumab

DRUG

gepants

atogepant, rimegepant

DRUG

combination of sumatriptan and naproxen

combination of sumatriptan and naproxen

DRUG

ditan

lasmiditan

Trial Locations (1)

00163

RECRUITING

IRCCS San Raffaele, Rome

All Listed Sponsors
lead

IRCCS San Raffaele Roma

OTHER